News
Pirfenidone could offer ‘viable’ heart failure treatment
An early phase trial of pirfenidone, which is typically used to treat lung fibrosis, has shown it may also help patients with a common form of heart failure.
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
An early phase trial of pirfenidone, which is typically used to treat lung fibrosis, has shown it may also help patients with a common form of heart failure.